Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients
Sponsor: Medical University of Warsaw
Summary
It is a randomized, single-center, controlled trial to evaluate the effectiveness of oral immunotherapy with low-dose sesame protein compared with standard treatment (elimination diet) in patients with sesame allergy.
Official title: Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
3 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
39
Start Date
2024-03-14
Completion Date
2027-03-01
Last Updated
2024-05-20
Healthy Volunteers
No
Conditions
Interventions
Dietary Supplement: Low dose OIT
Following the building-up phase (up to 14 months), patients will receive a daily low dose of sesame paste (300 mg sesame protein) mixed with well-tolerated fruit mousse or bread for 3 months (12 +/- 3 weeks).
Locations (1)
Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland